HIV Science Geneva 2027 brings the global HIV community together in Geneva, Switzerland, to advance science, share knowledge and strengthen collaboration.
Quick links to other pages:
HIV Science Geneva 2027 (HIVR4P 2027 and IAS 2027) will take place in Geneva, Switzerland, from 10 to 15 July. As a global hub for health, human rights and scientific research, Geneva offers a unique setting for international collaboration on the HIV response in a country with a long history of harm reduction and legal protections for key populations.
A hub for global health and human rights
Geneva is home to leading public health and human rights organizations, including many that are central to the HIV response. It also has a strong connection to HIV cure research through the “Geneva patient”, one of the few people considered “cured” of HIV.
A rights-based approach and a safe location for key populations
Switzerland is a leader in the HIV response, setting a high standard of dignity and rights for key populations. Its “four pillars” policy, introduced in 1991, broke new ground by approaching drug use as a public health issue rather than a criminal one.
Sex work is legal. Training programmes support people returning to society after prison. Trans people are gaining greater recognition. And same-sex marriage has been legal since 2022. Switzerland’s legal and social protections make Geneva a welcoming location for key populations attending the conferences.
Built for collaboration
HIV Science Geneva 2027 offers an important platform for global collaboration and for reinforcing partnerships that will take the HIV response forward.
The IAS is making both conferences as accessible as possible, particularly for participants from low- and middle-income countries, with a comprehensive scholarship programme and tiered fee structures.